Peak Pharmaceuticals, Inc. filed its 10-K on Dec 19, 2022 for the period ending Sep 30, 2020. In this report its auditor, Friedman LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.1 USD | -44.00% |
|
-44.00% | +21.39% |
1st Jan change | Capi. | |
---|---|---|
+21.39% | 43.94M | |
+18.52% | 3,317B | |
+18.50% | 95.04B | |
+16.95% | 89.51B | |
+48.86% | 57.5B | |
-20.85% | 49.11B | |
+35.19% | 48.55B | |
+87.65% | 43.81B | |
-33.78% | 39.87B | |
-3.71% | 27.19B |
- Stock Market
- Equities
- RMHI Stock
- News Retrieve Medical Holdings Inc
- Peak Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt